Picture of Barinthus Biotherapeutics logo

BRNS — Barinthus Biotherapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Barinthus Biotherapeutics PLC New Partnership Aims To Advance Vaccine Against Mers Coronavirus

Dec 21 (Reuters) - Barinthus Biotherapeutics PLC
 2ABy.F :
    * BARINTHUS BIOTHERAPEUTICS PLC: NEW PARTNERSHIP AIMS TO
ADVANCE
VACCINE AGAINST MERS CORONAVIRUS
    * BARINTHUS BIOTHERAPEUTICS PLC: COALITION FOR EPIDEMIC
PREPAREDNESS INNOVATIONS TO INVEST FUNDING OF UP TO $34.8
MILLION TO BARINTHUS BIO
    * BARINTHUS BIOTHERAPEUTICS:PARTNERSHIP AIMS TO FAST-TRACK
DEVELOPMENT OF VACCINE CANDIDATE, VTP-500, FOR PREVENTION OF
MIDDLE EAST RESPIRATORY SYNDROME
    * BARINTHUS BIOTHERAPEUTICS PLC-VACCINE WILL BE MADE
AVAILABLE TO
LOW-, MIDDLE-INCOME COUNTRIES AT PRICE NO HIGHER THAN COST OF
MANUFACTURING PLUS 10%

Source text for Eikon:  ID:nGNX376mtQ 
Further company coverage:  2ABy.F 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Barinthus Biotherapeutics

See all news